βLTBR/NIK/RELB

Kaiyu Xu1,2,3, Annika Kessler1,2,4, Federico Nichetti5,6

  • 1Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany.

概括

非正规的NF-κB (激活B细胞的核因子卡帕-光链增强器) 途径,特别是淋巴毒素-β/NF-κB诱导激酶/RelB轴,驱动胆管癌的生长. 抑制这种途径为这种侵袭性癌症提供了潜在的治疗策略.